750,000 Shares in Humana Inc. (NYSE:HUM) Acquired by Southpoint Capital Advisors LP

Southpoint Capital Advisors LP acquired a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 750,000 shares of the insurance provider's stock, valued at approximately $190,282,000. Humana accounts for approximately 4.5% of Southpoint Capital Advisors LP's holdings, making the stock its 6th largest position. Southpoint Capital Advisors LP owned approximately 0.62% of Humana as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in HUM. Transcend Capital Advisors LLC raised its position in Humana by 399.7% during the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock valued at $924,000 after purchasing an additional 2,914 shares in the last quarter. Retirement Systems of Alabama raised its position in Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after purchasing an additional 192,801 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in Humana by 7.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock valued at $244,811,000 after purchasing an additional 65,735 shares in the last quarter. Secure Asset Management LLC purchased a new stake in Humana during the fourth quarter valued at about $244,000. Finally, denkapparat Operations GmbH purchased a new stake in Humana during the fourth quarter valued at about $323,000. Institutional investors own 92.38% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on HUM shares. Guggenheim assumed coverage on Humana in a research report on Wednesday, April 9th. They set a "buy" rating and a $326.00 price target on the stock. Wall Street Zen upgraded Humana from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Royal Bank of Canada reiterated an "outperform" rating and issued a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Raymond James upgraded Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective on the stock in a report on Thursday, May 1st. Finally, Morgan Stanley reduced their price target on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a report on Wednesday, February 12th. Seventeen equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $286.81.

Humana Stock Down 8.0%

Shares of HUM traded down $19.60 during mid-day trading on Thursday, reaching $226.17. The company had a trading volume of 3,003,913 shares, compared to its average volume of 1,781,673. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a 50-day moving average price of $262.84 and a 200 day moving average price of $269.22. Humana Inc. has a 52 week low of $212.45 and a 52 week high of $406.46. The company has a market capitalization of $27.30 billion, a price-to-earnings ratio of 22.73, a price-to-earnings-growth ratio of 2.05 and a beta of 0.49.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. Humana had a return on equity of 11.70% and a net margin of 1.02%. The firm had revenue of $32.11 billion for the quarter, compared to analysts' expectations of $32 billion. During the same period in the previous year, the firm posted $7.23 EPS. The business's revenue for the quarter was up 8.4% compared to the same quarter last year. On average, sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.57%. Humana's payout ratio is currently 25.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.